See how top analysts and institutions rate HBAN — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Evercore ISI | Initiated | Outperform | $18 | 2025-10-21 |
| Wolfe Research | Upgrade | Peer Perform → Outperform | $21 | 2025-07-03 |
| Jefferies | Initiated | Buy | $20 | 2025-05-21 |
| TD Cowen | Initiated | Buy | $20 | 2025-05-15 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 3 | 13 | 4 | 0 | 1 |
| October 2025 | 3 | 13 | 4 | 0 | 1 |
| September 2025 | 3 | 13 | 3 | 0 | 2 |
| August 2025 | 3 | 13 | 3 | 0 | 2 |
The majority of institutional investors have issued a "Buy" rating for HBAN, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
